Skip to content

Clinical Study for Proctoclysis With Qingre Huatan Tongfu Decoction on Patients With Conscious Disturbance Caused by Craniocerebral Injury

Clinical Study for Proctoclysis With Qingre Huatan Tongfu Decoction on Patients With Conscious Disturbance Caused by Craniocerebral Injury

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024417
Enrollment
Unknown
Registered
2019-07-10
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conscious Disturbance by Craniocerebral Injury

Interventions

treatment group:Rectal drip of Qingre Huatan Tongfu Prescription and Routine comprehensive treatment
control group:Routine comprehensive treatment

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. It conforms to the diagnostic criteria of Western medicine for craniocerebral injury. 3. It conforms to the TCM diagnostic criteria of craniocerebral injury and the diagnostic criteria of TCM syndromes of phlegm heat and mental obstruction. 4. Acute stage: less than 2 weeks from onset, convalescent stage: 2 weeks to 6 months from onset; 5. The GCS score was less than 15; 6. Patients or family members agree to participate in the test.

Exclusion criteria

Exclusion criteria: 1. Encephalopathy caused by stroke, brain tumors, cerebral parasitic diseases, cerebral arteriovenous malformations, blood system diseases, etc.; 2. Complicated with serious primary diseases such as heart, liver, kidney, endocrine and hematopoietic system; 3. Pregnant or lactating women, patient with mental disorders; 4. Digestive tract diseases, such as anal sphincter relaxation, hemorrhoids, rectal cancer, fistula, anal fissure, intestinal necrosis or perforation, and those allergic to this medicine.

Design outcomes

Primary

MeasureTime frame
Glasgow coma scale;Awareness;The vegetative state;TCM Syndrome Therapeutic Score;glasgow outcome scale;

Countries

China

Contacts

Public ContactLyu Junying

The First Affiliated Hospital of Guangxi Medical University

lujunying007@163.com+86 13977119626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026